China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Xeligekimab in the Early Intervention of Psoriasis Vulgaris'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131589
Registration Time: 2026/09/04
Type: Interventional study
Primary Sponsor: Traditional Chinese and Western Medicine Hospital of Wuhan (Wuhan No1 Hospital)
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=334578
Published by HT Digital Content Services with permission from Health Daily Digest....